National Health Amendment (Pharmaceutical Benefits) Commencement Proclamation 2019

Overview

The National Health Amendment (Pharmaceutical Benefits) Commencement Proclamation 2019 was enacted in 2019 by the Honourable David Hurley AC DSC (Retd), the Governor-General of the Commonwealth of Australia, on the advice of the Federal Executive Council. This notifiable instrument was introduced to address specific commencement provisions outlined in the National Health Amendment (Pharmaceutical Benefits) Act 2019. The proclamation sets 5 December 2019 as the effective date for Schedule 2 of the Act, ensuring that the amendments pertaining to pharmaceutical benefits are implemented in a timely and orderly manner. This legislative action was taken to align with the policy objective of enhancing the Pharmaceutical Benefits Scheme (PBS) to better serve the health needs of Australians, reflecting the commitment to providing affordable and accessible healthcare.

Scope and Application

The National Health Amendment (Pharmaceutical Benefits) Commencement Proclamation 2019 establishes the commencement date for Schedule 2 of the National Health Amendment (Pharmaceutical Benefits) Act 2019, which is set to be 5 December 2019. This Act applies to the Commonwealth of Australia and its territories, influencing the pharmaceutical sector by implementing amendments to the Pharmaceutical Benefits Scheme (PBS). The legislation impacts entities such as pharmaceutical companies, healthcare providers, and patients who are part of the PBS, thereby affecting their operations, transactions, and access to medication. The geographic reach of this Act is nationwide, ensuring uniform application across all states and territories. There are no specific exclusions or exemptions outlined in this Proclamation, but the Act's broader provisions may include certain thresholds or conditions that need to be met for eligibility and participation within the PBS framework. The scope of this legislation can be further defined or extended through subordinate instruments, which may provide additional regulations or clarifications to ensure effective implementation and compliance.

Key Provisions

The main provisions of the National Health Amendment (Pharmaceutical Benefits) Commencement Proclamation 2019 (F2019N00099) are found in its sole section, which provides that the commencement day for Schedule 2 of the National Health Amendment (Pharmaceutical Benefits) Act 2019 is 5 December 2019 (section 1). This means that the changes and new provisions outlined in Schedule 2 of the parent Act will officially come into effect on this date. These changes might relate to the Pharmaceutical Benefits Scheme (PBS), affecting how medications are subsidised, listed, or funded. The Act imposes obligations on relevant parties, such as the Minister for Health, to ensure that all necessary preparations are made for the commencement of Schedule 2. This includes informing stakeholders, updating relevant systems, and ensuring that all administrative and operational changes are in place before the commencement date. The Minister must also ensure compliance with any transitional provisions that might be outlined in Schedule 2, which could involve specific actions to be taken before or on the commencement day. Any failure to comply with the provisions of the National Health Amendment (Pharmaceutical Benefits) Act 2019, once Schedule 2 is in effect, could result in legal consequences. While the Proclamation itself does not detail specific offences or penalties, breaches of the parent Act may lead to civil or criminal penalties. The exact nature and severity of these penalties would depend on the specific provisions of Schedule 2. For example, non-compliance with listing or funding requirements could result in fines or other administrative actions, while more serious breaches might lead to criminal charges and higher penalties. The maximum penalties for breaches are not specified in the Proclamation but would be detailed in the parent Act. The National Health Amendment (Pharmaceutical Benefits) Commencement Proclamation 2019 thus sets a clear date for the implementation of significant changes to the PBS, establishing a framework for compliance and enforcement. It underscores the importance of timely and effective action by the Minister for Health and other relevant parties to ensure the smooth transition to the new provisions. The potential legal and financial repercussions for non-compliance highlight the critical need for adherence to the new requirements set out in the parent Act.